Press-release for stocks related to treatment

Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

america tags : Treatment

save search

KalVista Pharmaceuticals Presents Real-World Data on Burden of Treatment and HAE Attack Journey at the 2024 HAEi Regional Conference Americas
Published: 2024-03-18 (Crawled : 12:00) - biospace.com/
KALV | $11.57 0.61% 46K

|

Health Technology

| -2.35% | O: -0.08% H: 3.61% C: 0.59%
conference treatment pharmaceuticals

Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million, 42% of market growth is expected in North America, Technavio
Published: 2024-03-12 (Crawled : 04:00) - prnewswire.com
ELDN | $1.91 -4.02% 200K

|

| -7.51% | O: 1.73% H: 1.7% C: -7.39%
SNY | News | $46.34 2.09% 620K

|

Health Technology

| -5.84% | O: 0.01% H: 0.0% C: 0.0%
DNLI | $16.455 -0.87% 120K

|

Health Technology

| -20.06% | O: -0.6% H: 0.74% C: -3.66%
BCLI | $0.5845 13.65% 790K

|

Health Technology

| 55.02% | O: -2.43% H: 2.8% C: -4.02%
BIIB | $191.45 0.49% 310K

|

Health Technology

| -15.18% | O: -0.32% H: 0.18% C: -0.86%
expected sclerosis treatment growth market

FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum
Published: 2024-03-05 (Crawled : 14:00) - biospace.com/
HUGE | $0.6167 1.22% 29K

|

Process Industries

| -27.47% | O: -13.48% H: 15.52% C: 12.05%
pharma positive sclerosis treatment research results lucid-21-302 study

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Published: 2024-03-01 (Crawled : 12:30) - globenewswire.com
TGTX | News | $13.735 -1.82% 1.2M

|

Health Technology

| -18.76% | O: 1.86% H: 4.79% C: 2.39%
briumvi presentation sclerosis treatment research therapeutics

FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum
Published: 2024-02-20 (Crawled : 14:30) - prnewswire.com
FBLG | $10.68 -3.0% 9.7K

|

| -18.59% | O: 7.33% H: 0.0% C: -14.77%
sclerosis treatment research preclinical

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Published: 2024-02-20 (Crawled : 12:30) - globenewswire.com
TGTX | News | $13.735 -1.82% 1.2M

|

Health Technology

| 1.16% | O: -0.58% H: 0.76% C: -3.78%
briumvi sclerosis treatment research therapeutics

Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio
Published: 2024-01-09 (Crawled : 03:00) - prnewswire.com
ALPMF | $9.17 16K

|

Health Technology

| -22.38% | O: 0.16% H: 0.0% C: -3.88%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| -11.87% | O: -0.24% H: 0.0% C: 0.0%
ALPMY | $9.47 520K

|

| -23.94% | O: -1.22% H: 0.0% C: -0.72%
NVS | $93.815 1.35% 410K

|

Health Technology

| -13.07% | O: -0.46% H: 0.74% C: -0.19%
SNY | News | $46.34 2.09% 620K

|

Health Technology

| -11.68% | O: 0.74% H: 0.0% C: 0.0%
AMGN | $266.895 1.58% 950K

|

Health Technology

| -14.78% | O: -0.92% H: 0.63% C: -0.25%
america cancer treatment market

Amyotrophic Lateral Sclerosis Treatment Market size to grow by USD 663.7 million from 2023 to 2028, North America to account for 42% of market growth - Technavio
Published: 2023-12-07 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 600K

|

Health Technology

| 2.34% | O: 2.06% H: 0.82% C: 0.82%
ELDN | $1.91 -4.02% 200K

|

| 26.98% | O: -1.59% H: 7.26% C: 2.42%
SNY | News | $46.34 2.09% 620K

|

Health Technology

| -0.46% | O: 1.07% H: 0.0% C: 0.0%
DNLI | $16.455 -0.87% 120K

|

Health Technology

| -7.47% | O: -0.21% H: 0.08% C: -1.76%
BCLI | $0.5845 13.65% 790K

|

Health Technology

| 129.73% | O: 0.0% H: 3.56% C: -9.77%
BIIB | $191.45 0.49% 310K

|

Health Technology

| -18.39% | O: -0.61% H: 1.33% C: 0.69%
america sclerosis treatment growth market

Ewing's Sarcoma Treatment Market to grow by USD 205.09 million from 2024-2028; North America to account for 48% of market growth - Technavio
Published: 2023-11-20 (Crawled : 19:00) - prnewswire.com
NVS | $93.815 1.35% 410K

|

Health Technology

| -2.28% | O: 0.91% H: 0.6% C: 0.27%
GSK | $39.685 1.06% 380K

|

Health Technology

| 12.79% | O: 0.51% H: 0.77% C: 0.26%
BAX | $39.945 0.74% 430K

|

Health Technology

| 11.45% | O: 0.39% H: 0.2% C: -0.17%
america treatment growth market

Expert Panelists Advocate Use of Daxor’s Technology to Optimize Treatment at Heart Failure Society of America Annual Scientific Meeting
Published: 2023-10-13 (Crawled : 12:00) - globenewswire.com
DXR | $9.74 920

|

Health Technology

| 7.21% | O: 0.0% H: 0.0% C: -1.11%
america treatment meeting heart technology

Flow Diversion Aneurysm Treatment Market to grow by USD 2.11 billion from 2022 to 2027, North America to account for 38% of market growth - Technavio
Published: 2023-09-24 (Crawled : 04:20) - prnewswire.com
MDT | $79.49 0.38% 1.4M

|

Health Technology

| Email alert Add to watchlist
TRUMY | $16.507 34K

|

| Email alert Add to watchlist
TRUMF | $16.928 1.9K

|

Health Technology

| Email alert Add to watchlist
NSPR 4 | $2.1409 5.6K

|

Health Technology

| Email alert Add to watchlist
america treatment flow growth market

Scar Treatment Market size to grow by USD 13.17 billion from 2022-2027 | North America to account for 37% of market growth - Technavio
Published: 2023-09-21 (Crawled : 06:00) - prnewswire.com
BHC | $8.655 0.64% 750K

|

Health Technology

| 4.8% | O: -1.2% H: 2.79% C: 1.82%
america treatment growth market

Optic Nerves Disorder Treatment Market Rises: North America Takes the Helm
Published: 2023-09-14 (Crawled : 00:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 12.52% | O: 1.84% H: 0.0% C: 0.0%
PFE A | $25.81 1.65% 15M

|

Health Technology

| -25.41% | O: 0.47% H: 0.41% C: -0.26%
NVS | $93.815 1.35% 410K

|

Health Technology

| -7.64% | O: 0.28% H: 1.0% C: 0.76%
ABBV | News | $164.91 0.15% 1.2M

|

Health Technology

| 10.59% | O: 1.78% H: 1.76% C: 1.07%
america treatment market

Female Sexual Dysfunction Treatment Market to grow by USD 7.76 billion from 2022-2027; North America to account for 61% of market growth - Technavio
Published: 2023-09-11 (Crawled : 08:00) - prnewswire.com
ENDPQ | $0.0006 3.4K

|

| -60.0% | O: 0.0% H: 10.0% C: 0.0%
VTRS | $11.2 0.72% 1M

|

Health Technology

| 9.99% | O: 0.4% H: 0.69% C: -1.38%
america treatment growth market

UpHealth’s Transformations Treatment Center Recognized as One of America's Best Addiction Treatment Centers for 2023
Published: 2023-09-06 (Crawled : 20:00) - globenewswire.com
UPH | $0.3 9.13% 0.0% 350K

|

Professional, Scientific, and T...

| Email alert Add to watchlist
one treatment

Global Infectious Enteritis Treatment Market: A Comprehensive Analysis, with Focus on Antibiotics and the Dominance of North America; Forecast Growth at 4.9% CAGR
Published: 2023-08-22 (Crawled : 14:49) - prnewswire.com
GLAXF | $20.2 510

|

Health Technology

| 18.03% | O: 1.97% H: 0.0% C: -0.47%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| 11.08% | O: -1.32% H: 0.0% C: 0.0%
NVS | $93.815 1.35% 410K

|

Health Technology

| -9.61% | O: 0.1% H: 0.07% C: -0.48%
JNJ | News | $146.39 0.45% 1.8M

|

Health Technology

| -14.54% | O: -1.98% H: 0.0% C: 0.0%
GSK | $39.685 1.06% 380K

|

Health Technology

| 14.62% | O: 0.49% H: 0.23% C: -0.29%
treatment antibiotics global growth

TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI™ (ublituximab-xiiy) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Published: 2023-02-24 (Crawled : 13:00) - biospace.com/
TGTX | News | $13.735 -1.82% 1.2M

|

Health Technology

| -14.95% | O: -2.49% H: 1.2% C: -2.12%
treatment trials research therapeutics presentation sclerosis multiple sclerosis

Pasithea Therapeutics Chairman, Prof. Lawrence Steinman to Deliver Dr. Kenneth P. Johnson Lecture at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
Published: 2023-02-23 (Crawled : 15:00) - biospace.com/
KTTA | $7.15 270

|

| 1249.31% | O: -1.87% H: 2.85% C: -3.85%
treatment research therapeutics sclerosis

FSD Pharma Presenting Two Scientific Posters on Preclinical Toxicology and Efficacy Data of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2023 Forum
Published: 2023-02-23 (Crawled : 14:00) - fsdpharma.com
HUGE | $0.6167 1.22% 29K

|

Process Industries

| -65.75% | O: 0.0% H: 2.22% C: 0.0%
treatment pharma research preclinical lucid-21-302 sclerosis

Outlook on the Scar Treatment Global Market to 2030: Players Include Smith & Nephew, Merz North America, LUMENIS, Enaltus, Sonoma Pharmaceuticals and Molnlycke Health Care
Published: 2023-02-23 (Crawled : 01:00) - prnewswire.com
PRGO | $30.22 0.94% 140K

|

Health Technology

| -17.92% | O: 0.41% H: 0.63% C: -0.49%
SNOA | $0.156 -0.38% 69K

|

Health Technology

| -88.89% | O: 0.0% H: 3.78% C: -2.08%
treatment care pharmaceuticals global health market

← Previous
1
2
3
Next →

Gainers vs Losers

78%

22%

Top 10 Gainers

AGBA | News | $1.22 205.0% 86M

|

NVFY | $3.45 63.51% 20M

|

Consumer Durables

EGOX | $0.054 50.0% 290M

|

CHRO | $1.66 35.51% 70K

|

INDO | $5.43 33.09% 10M

|

Energy Minerals

ZCMD | $1.86 28.28% 29M

|

Commercial Services

PAPL | $2.07 26.22% 550K

|

RWOD | $10.08 26.05% 5.6M

|

HUSA 4 | $2.07 23.95% 2.1M

|

Energy Minerals

TPET | $0.4001 22.02% 35M

|

Your saved searches

Save your searches and get alerts when important news are released.